Published in BMC Health Serv Res on September 22, 2014
Adverse Effects of GLP-1 Receptor Agonists. Rev Diabet Stud (2015) 0.82
How Consistent is the Relationship between Improved Glucose Control and Modelled Health Outcomes for People with Type 2 Diabetes Mellitus? a Systematic Review. Pharmacoeconomics (2016) 0.75
Long-Term Effectiveness and Cost-Effectiveness of Metformin Combined with Liraglutide or Exenatide for Type 2 Diabetes Mellitus Based on the CORE Diabetes Model Study. PLoS One (2016) 0.75
The place of DPP-4 inhibitors in the treatment algorithm of diabetes type 2: a systematic review of cost-effectiveness studies. Eur J Health Econ (2016) 0.75
Cost-Effectiveness of Liraglutide Versus Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus in the UK. Diabetes Ther (2017) 0.75
Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med (2008) 47.90
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med (2008) 38.76
Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med (2008) 25.70
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia (2012) 10.74
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet (2009) 9.32
The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol (2011) 5.55
Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial. Diabetologia (2009) 4.81
The CORE Diabetes Model: Projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making. Curr Med Res Opin (2004) 2.44
Assessing the impact of complications on the costs of Type II diabetes. Diabetologia (2002) 2.11
One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial. Int J Clin Pract (2011) 1.59
Validation of the CORE Diabetes Model against epidemiological and clinical studies. Curr Med Res Opin (2004) 1.38
An overview of the pharmacokinetics, efficacy and safety of liraglutide. Diabetes Res Clin Pract (2012) 1.14
The epidemiology of Type 2 diabetes mellitus in Greek adults: the ATTICA study. Diabet Med (2005) 1.14
Efficacy and safety of switching from the DPP-4 inhibitor sitagliptin to the human GLP-1 analog liraglutide after 52 weeks in metformin-treated patients with type 2 diabetes: a randomized, open-label trial. Diabetes Care (2012) 1.04
Estimating the direct cost of Type 2 diabetes in Greece: the effects of blood glucose regulation on patient cost. Diabet Med (2010) 0.98
Cost-utility analysis of liraglutide compared with sulphonylurea or sitagliptin, all as add-on to metformin monotherapy in Type 2 diabetes mellitus. Diabet Med (2012) 0.91
Economic evaluation of treatment strategies for patients suffering acute myocardial infarction in Greece. Hellenic J Cardiol (2005) 0.91
Long-term clinical and economic outcomes associated with liraglutide versus sitagliptin therapy when added to metformin in the treatment of type 2 diabetes: a CORE Diabetes Model analysis. J Med Econ (2012) 0.88
Incretin therapy for type 2 diabetes in Spain: a cost-effectiveness analysis of liraglutide versus sitagliptin. Diabetes Ther (2013) 0.87
Evaluating the long-term cost-effectiveness of liraglutide versus exenatide BID in patients with type 2 diabetes who fail to improve with oral antidiabetic agents. Clin Ther (2011) 0.87
Economic evaluation of hemodialysis: implications for technology assessment in Greece. Int J Technol Assess Health Care (2005) 0.86
Cost-effectiveness analysis of ranibizumab versus verteporfin photodynamic therapy, pegaptanib sodium, and best supportive care for the treatment of age-related macular degeneration in Greece. Clin Ther (2012) 0.85
Trends in the management of type 2 diabetes and its prescription drug costs in Greece (1998 & 2006). Exp Clin Endocrinol Diabetes (2009) 0.83
Results of a model analysis of the cost-effectiveness of liraglutide versus exenatide added to metformin, glimepiride, or both for the treatment of type 2 diabetes in the United States. Clin Ther (2010) 0.81
Economic evaluation of clopidogrel in acute coronary syndrome patients without ST-segment elevation in Greece: a cost-utility analysis. Appl Health Econ Health Policy (2012) 0.77
Clopidogrel versus aspirin in patients with atherothrombosis: a CAPRIE-based cost-effectiveness model for Greece. Appl Health Econ Health Policy (2012) 0.77
Cost-of-illness study of patients subjected to cardiac rhythm management devices implantation: results from a single tertiary centre. Europace (2012) 2.05
Plasma asymmetric dimethylarginine and mortality in patients with acute decompensation of chronic heart failure. Heart (2012) 1.56
Intensive insulin treatment and QT-interval. Diabetes Care (2003) 1.40
Factors influencing prescribing behaviour of physicians in Greece and Cyprus: results from a questionnaire based survey. BMC Health Serv Res (2009) 1.35
Television viewing and food habits in toddlers and preschoolers in Greece: the GENESIS study. Eur J Pediatr (2008) 1.11
Long-term fish intake is associated with better lipid profile, arterial blood pressure, and blood glucose levels in elderly people from Mediterranean islands (MEDIS epidemiological study). Med Sci Monit (2007) 1.09
Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction. Exp Gerontol (2002) 1.09
Maternal perceptions of their child's weight status: the GENESIS study. Public Health Nutr (2008) 1.08
Epidemiology of acute coronary syndromes in a Mediterranean country; aims, design and baseline characteristics of the Greek study of acute coronary syndromes (GREECS). BMC Public Health (2005) 1.07
Photoselective GreenLight™ laser vaporization versus transurethral resection of the prostate in Greece: a comparative cost analysis. J Endourol (2011) 1.00
Heart rate variability in advanced chronic kidney disease with or without diabetes: midterm effects of the initiation of chronic haemodialysis therapy. Nephrol Dial Transplant (2010) 0.99
Simultaneous bilateral facial palsy in a diabetic patient. Diabetes Care (2004) 0.96
Long-term follow-up after radiofrequency catheter ablation for atrial fibrillation. Europace (2008) 0.96
Effect of cementless acetabular component orientation, position, and containment in total hip arthroplasty for congenital hip disease. J Arthroplasty (2010) 0.93
Obesity and television watching in preschoolers in Greece: the GENESIS study. Obesity (Silver Spring) (2009) 0.93
Patient preference and willingness-to-pay for Humalog Mix25 relative to Humulin 30/70: a multicountry application of a discrete choice experiment. Value Health (2004) 0.93
Diet quality of preschoolers in Greece based on the Healthy Eating Index: the GENESIS study. J Am Diet Assoc (2009) 0.92
Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes. Cardiovasc Diabetol (2006) 0.92
Pharmacoeconomic considerations in the treatment of breast cancer. Clinicoecon Outcomes Res (2010) 0.92
Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study. BMC Psychiatry (2011) 0.91
Associations of several anthropometric indices with insulin resistance in children: The Children Study. Acta Paediatr (2008) 0.91
Reporting distress and quality of life of patients with diabetes mellitus in primary and secondary care in Greece. Ment Health Fam Med (2008) 0.90
Factors associated with delay in seeking health care for hospitalized patients with acute coronary syndromes: the GREECS study. Hellenic J Cardiol (2007) 0.90
Cost-effectiveness of atrial fibrillation catheter ablation. Europace (2008) 0.88
Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK. Eur J Health Econ (2003) 0.87
Survival from breast cancer in relation to access to tertiary healthcare, body mass index, tumor characteristics and treatment: a Hellenic Cooperative Oncology Group (HeCOG) study. Eur J Epidemiol (2012) 0.87
Toll/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction. Cardiovasc Diabetol (2011) 0.87
Comparison of filgrastim and pegfilgrastim to prevent neutropenia and maintain dose intensity of adjuvant chemotherapy in patients with breast cancer. Support Care Cancer (2014) 0.85
Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals. Cardiovasc Diabetol (2012) 0.85
Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece. Clinicoecon Outcomes Res (2012) 0.85
Physicians' perceptions and adherence to guidelines for the management of hypertension: a national, multicentre, prospective study. Int J Hypertens (2012) 0.85
Total hip arthroplasty in patients with high dislocation: a concise follow-up, at a minimum of fifteen years, of previous reports. J Bone Joint Surg Am (2011) 0.85
Association of creatinine clearance and in-hospital mortality in patients with acute coronary syndromes: the GREECS study. Circ J (2007) 0.85
Correlation between increased serum sFas levels and microalbuminuria in type 1 diabetic patients. Med Princ Pract (2007) 0.84
Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario. Europace (2011) 0.84
A systematic review of the effectiveness of taxes on nonalcoholic beverages and high-in-fat foods as a means to prevent obesity trends. Clinicoecon Outcomes Res (2013) 0.83
Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association. Eur Heart J (2013) 0.83
Regression of paroxysmal atrial fibrillation associated with thiazolidinedione therapy. Int J Cardiol (2007) 0.82
Health economics and outcomes research: a new challenge and field of action for the European Heart Rhythm Association. Europace (2010) 0.82
Costs and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in the Netherlands. Value Health (2008) 0.81
Factors associated with the use of pap smear testing in Greece. J Womens Health (Larchmt) (2010) 0.81
Computer simulation of the human respiratory system for educational purposes. Comput Inform Nurs (2004) 0.81
Intensive insulin treatment reduces transient ischaemic episodes during acute coronary events in diabetic patients. Acta Cardiol (2002) 0.81
Prediction of long-term functional outcome in patients with acute ischemic non-embolic stroke. Atherosclerosis (2008) 0.81
The public's and doctors' perceived role in participation in setting health care priorities in Greece. Hellenic J Cardiol (2010) 0.81
Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe. Lung Cancer (2004) 0.81
Severe Plasmodium vivax malaria complicated with acute respiratory distress syndrome: a case associated with focal autochthonous transmission in Greece. Vector Borne Zoonotic Dis (2014) 0.81
Plasma soluble α-klotho protein levels in premature and term neonates: correlations with growth and metabolic parameters. Eur J Endocrinol (2012) 0.80
Self-reported prevalence of atherothrombosis in a general population sample of adults in Greece; a telephone survey. BMC Cardiovasc Disord (2011) 0.80
Comparative performance of three metabolic syndrome definitions in the prediction of acute coronary syndrome. Intern Med (2009) 0.80
Factors associated with the use of preventive services by women in Greece. Eur J Public Health (2010) 0.80
An age-dependent diet-modified effect of the PPARγ Pro12Ala polymorphism in children. Metabolism (2010) 0.80
Prevalence of obesity and body mass index correlates in a representative sample of Cretan school children. Int J Pediatr Obes (2010) 0.80
The impact of moderate aerobic physical training on left ventricular mass, exercise capacity and blood pressure response during treadmill testing in borderline and mildly hypertensive males. Hellenic J Cardiol (2011) 0.80
Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece. BMC Health Serv Res (2014) 0.80
The humanistic and economic burden of venous thromboembolism in cancer patients: a systematic review. Blood Coagul Fibrinolysis (2015) 0.79
Regional endocardial left atrial voltage and electrogram fractionation in patients with atrial fibrillation. J Cardiovasc Electrophysiol (2008) 0.79
Systolic blood pressure on admission predicts in-hospital mortality among patients presenting with acute coronary syndromes: the Greek study of acute coronary syndromes. J Clin Hypertens (Greenwich) (2008) 0.79
The economic burden of atherothrombosis in Greece: results from the THESIS study. Eur J Health Econ (2012) 0.79
The cost effectiveness of implantable cardioverter defibrillators: a systematic review of economic evaluations. Appl Health Econ Health Policy (2014) 0.79
Economic evaluation of alternative assisted reproduction techniques in management of infertility in Greece. Clinicoecon Outcomes Res (2012) 0.79
Characteristics and in-hospital mortality of diabetics and nondiabetics with an acute coronary syndrome; the GREECS study. Clin Cardiol (2007) 0.78
Quality of life measurement in patients with hypertension in Cyprus. Hellenic J Cardiol (2011) 0.78
Development of a diet-lifestyle quality index for young children and its relation to obesity: the Preschoolers Diet-Lifestyle Index. Public Health Nutr (2010) 0.78
Arterial stiffness predicts risk for long-term recurrence in patients with type 2 diabetes admitted for acute coronary event. Diabetes Res Clin Pract (2012) 0.78
Management of type 2 diabetes and its prescription drug cost before and during the economic crisis in Greece: an observational study. BMC Endocr Disord (2014) 0.78
Does smoking status affect the association between baseline white blood cell count and in-hospital mortality of patients presented with acute coronary syndrome? The Greek study of acute coronary syndromes (GREECS). Int J Cardiol (2007) 0.78
Effect of intravenous insulin administration on left ventricular performance during non-ST-elevation acute coronary events in patients with diabetes mellitus. Am J Cardiol (2003) 0.77
Clopidogrel versus aspirin in patients with atherothrombosis: a CAPRIE-based cost-effectiveness model for Greece. Appl Health Econ Health Policy (2012) 0.77
Prognostic value of the carotid artery intima-media thickness for the presence and severity of coronary artery disease in type 2 diabetic patients. Diabetes Care (2003) 0.77
Economic evaluation of clopidogrel in acute coronary syndrome patients without ST-segment elevation in Greece: a cost-utility analysis. Appl Health Econ Health Policy (2012) 0.77
Metabolic syndrome and its components as predictors of all-cause mortality and coronary heart disease in type 2 diabetic patients. Atherosclerosis (2006) 0.77
Development and validation of two equations estimating body composition for overweight and obese postmenopausal women. Maturitas (2009) 0.77
Analysis of published economic evaluations of angiotensin receptor blockers. Hellenic J Cardiol (2009) 0.77
Atrial fibrillation ablation: a cost or an investment? Europace (2011) 0.76
Early evaluation of an organised mammography screening program in Greece 2004-2009. Cancer Epidemiol (2011) 0.76
Anatomic characteristics of culprit sites in acute coronary syndromes. J Interv Cardiol (2008) 0.76
Metabolic syndrome and its components as predictors of ischemic stroke in type 2 diabetic patients. Stroke (2008) 0.76
Economic evaluation of rivaroxaban in stroke prevention for patients with atrial fibrillation in Greece. Cost Eff Resour Alloc (2014) 0.76
Sex-related characteristics in hospitalized patients with acute coronary syndromes--the Greek Study of Acute Coronary Syndromes (GREECS). Heart Vessels (2007) 0.76
Evaluation of IScore validity in a Greek cohort of patients with type 2 diabetes. BMC Neurol (2013) 0.75
Idiopathic autoimmune hemolytic anemia due to lecithin overdose: a case report. Cases J (2009) 0.75
Economic evaluation of statins in high-risk patients treated for primary and secondary prevention of cardiovascular disease in Greece. Clinicoecon Outcomes Res (2012) 0.75
Comprehensive overview: efficacy, tolerability, and cost-effectiveness of irbesartan. Vasc Health Risk Manag (2013) 0.75
Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece. BMC Health Serv Res (2013) 0.75
Atrial arrhythmias following ostial or circumferential pulmonary vein ablation. J Interv Card Electrophysiol (2006) 0.75
Anemia and early mortality in patients with decompensation of chronic heart failure. Cardiology (2011) 0.75
Staged circumferential and ostial pulmonary vein ablation for the treatment of paroxysmal atrial fibrillation. Pacing Clin Electrophysiol (2007) 0.75
Proarrhythmic effects of atrial fibrillation ablation techniques. Hellenic J Cardiol (2006) 0.75
Complications Related to Cardiac Rhythm Management Device Therapy and Their Financial Implication: A Prospective Single-Center TwoYear Survey. Hellenic J Cardiol (2016) 0.75
Three-dimensional analysis of the left anterior descending coronary artery: comparison with conventional coronary angiograms. Coron Artery Dis (2008) 0.75
Health technology assessment: what is it? Current status and perspectives in the field of electrophysiology. Europace (2011) 0.75
Surgical site infections and compliance with perioperative antimicrobial prophylaxis in Greek children. Infect Control Hosp Epidemiol (2014) 0.75
Cost effectiveness of treatments for non-ST-segment elevation acute coronary syndrome. Pharmacoeconomics (2014) 0.75
Direct versus predilatation drug-eluting stenting: a randomized clinical trial. J Invasive Cardiol (2006) 0.75
Stress cardiac magnetic resonance reveals myocardial perfusion impairment in asymptomatic diabetes mellitus type I, missed by the routine non-invasive evaluation. Int J Cardiol (2013) 0.75